Global Central Nervous System (CNS) Drug Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 92

Published Date: 12 Oct 2021

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The Central Nervous System (CNS) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Central Nervous System (CNS) Drug size is estimated to be USD  million in 2026 from USD  million in 2020, with a change  % between 2020 and 2021. The global Central Nervous System (CNS) Drug market size is expected to grow at a CAGR of  % for the next five years.

Market segmentation
Central Nervous System (CNS) Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    Prescription Drugs
    OTC

Market segment by Application, can be divided into
    MS Therapeutics
    Antipsychotic Drugs
    Depression Drugs
    Epilepsy Drugs
    Others

Market segment by players, this report covers
    Johnson & Johnson
    Pfizer Inc
    Novartis AG
    GSK
    Eli Lilly
    Teva
    Otsuka Pharmaceutical Co., Ltd
    Biogen Inc
    Boehringer Ingelheim
    Roche
    UCB
    Tekeda
    Shanghai Fosun
    Jiangsu Nhwa Pharmaceutical Co., Ltd.

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Central Nervous System (CNS) Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Central Nervous System (CNS) Drug, with revenue, gross margin and global market share of Central Nervous System (CNS) Drug from 2019 to 2021.
Chapter 3, the Central Nervous System (CNS) Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Central Nervous System (CNS) Drug market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Central Nervous System (CNS) Drug research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Central Nervous System (CNS) Drug
    1.2 Classification of Central Nervous System (CNS) Drug by Type
        1.2.1 Overview: Global Central Nervous System (CNS) Drug Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Central Nervous System (CNS) Drug Revenue Market Share by Type in 2020
        1.2.3 Prescription Drugs
        1.2.4 OTC
    1.3 Global Central Nervous System (CNS) Drug Market by Application
        1.3.1 Overview: Global Central Nervous System (CNS) Drug Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 MS Therapeutics
        1.3.3 Antipsychotic Drugs
        1.3.4 Depression Drugs
        1.3.5 Epilepsy Drugs
        1.3.6 Others
    1.4 Global Central Nervous System (CNS) Drug Market Size & Forecast
    1.5 Global Central Nervous System (CNS) Drug Market Size and Forecast by Region
        1.5.1 Global Central Nervous System (CNS) Drug Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Central Nervous System (CNS) Drug Market Size by Region, (2016-2021)
        1.5.3 North America Central Nervous System (CNS) Drug Market Size and Prospect (2016-2026)
        1.5.4 Europe Central Nervous System (CNS) Drug Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Central Nervous System (CNS) Drug Market Size and Prospect (2016-2026)
        1.5.6 South America Central Nervous System (CNS) Drug Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Central Nervous System (CNS) Drug Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Central Nervous System (CNS) Drug Market Drivers
        1.6.2 Central Nervous System (CNS) Drug Market Restraints
        1.6.3 Central Nervous System (CNS) Drug Trends Analysis

2 Company Profiles
    2.1 Johnson & Johnson
        2.1.1 Johnson & Johnson Details
        2.1.2 Johnson & Johnson Major Business
        2.1.3 Johnson & Johnson Central Nervous System (CNS) Drug Product and Solutions
        2.1.4 Johnson & Johnson Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Johnson & Johnson Recent Developments and Future Plans
    2.2 Pfizer Inc
        2.2.1 Pfizer Inc Details
        2.2.2 Pfizer Inc Major Business
        2.2.3 Pfizer Inc Central Nervous System (CNS) Drug Product and Solutions
        2.2.4 Pfizer Inc Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Pfizer Inc Recent Developments and Future Plans
    2.3 Novartis AG
        2.3.1 Novartis AG Details
        2.3.2 Novartis AG Major Business
        2.3.3 Novartis AG Central Nervous System (CNS) Drug Product and Solutions
        2.3.4 Novartis AG Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Novartis AG Recent Developments and Future Plans
    2.4 GSK
        2.4.1 GSK Details
        2.4.2 GSK Major Business
        2.4.3 GSK Central Nervous System (CNS) Drug Product and Solutions
        2.4.4 GSK Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 GSK Recent Developments and Future Plans
    2.5 Eli Lilly
        2.5.1 Eli Lilly Details
        2.5.2 Eli Lilly Major Business
        2.5.3 Eli Lilly Central Nervous System (CNS) Drug Product and Solutions
        2.5.4 Eli Lilly Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Eli Lilly Recent Developments and Future Plans
    2.6 Teva
        2.6.1 Teva Details
        2.6.2 Teva Major Business
        2.6.3 Teva Central Nervous System (CNS) Drug Product and Solutions
        2.6.4 Teva Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 Teva Recent Developments and Future Plans
    2.7 Otsuka Pharmaceutical Co., Ltd
        2.7.1 Otsuka Pharmaceutical Co., Ltd Details
        2.7.2 Otsuka Pharmaceutical Co., Ltd Major Business
        2.7.3 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product and Solutions
        2.7.4 Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Otsuka Pharmaceutical Co., Ltd Recent Developments and Future Plans
    2.8 Biogen Inc
        2.8.1 Biogen Inc Details
        2.8.2 Biogen Inc Major Business
        2.8.3 Biogen Inc Central Nervous System (CNS) Drug Product and Solutions
        2.8.4 Biogen Inc Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Biogen Inc Recent Developments and Future Plans
    2.9 Boehringer Ingelheim
        2.9.1 Boehringer Ingelheim Details
        2.9.2 Boehringer Ingelheim Major Business
        2.9.3 Boehringer Ingelheim Central Nervous System (CNS) Drug Product and Solutions
        2.9.4 Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Boehringer Ingelheim Recent Developments and Future Plans
    2.10 Roche
        2.10.1 Roche Details
        2.10.2 Roche Major Business
        2.10.3 Roche Central Nervous System (CNS) Drug Product and Solutions
        2.10.4 Roche Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Roche Recent Developments and Future Plans
    2.11 UCB
        2.11.1 UCB Details
        2.11.2 UCB Major Business
        2.11.3 UCB Central Nervous System (CNS) Drug Product and Solutions
        2.11.4 UCB Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 UCB Recent Developments and Future Plans
    2.12 Tekeda
        2.12.1 Tekeda Details
        2.12.2 Tekeda Major Business
        2.12.3 Tekeda Central Nervous System (CNS) Drug Product and Solutions
        2.12.4 Tekeda Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.12.5 Tekeda Recent Developments and Future Plans
    2.13 Shanghai Fosun
        2.13.1 Shanghai Fosun Details
        2.13.2 Shanghai Fosun Major Business
        2.13.3 Shanghai Fosun Central Nervous System (CNS) Drug Product and Solutions
        2.13.4 Shanghai Fosun Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.13.5 Shanghai Fosun Recent Developments and Future Plans
    2.14 Jiangsu Nhwa Pharmaceutical Co., Ltd.
        2.14.1 Jiangsu Nhwa Pharmaceutical Co., Ltd. Details
        2.14.2 Jiangsu Nhwa Pharmaceutical Co., Ltd. Major Business
        2.14.3 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product and Solutions
        2.14.4 Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue, Gross Margin and Market Share (2019-2021)
        2.14.5 Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Central Nervous System (CNS) Drug Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Central Nervous System (CNS) Drug Players Market Share
        3.2.2 Top 10 Central Nervous System (CNS) Drug Players Market Share
        3.2.3 Market Competition Trend
    3.3 Central Nervous System (CNS) Drug Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Central Nervous System (CNS) Drug Revenue and Market Share by Type (2016-2021)
    4.2 Global Central Nervous System (CNS) Drug Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Central Nervous System (CNS) Drug Revenue Market Share by Application (2016-2021)
    5.2 Central Nervous System (CNS) Drug Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Central Nervous System (CNS) Drug Revenue by Type (2016-2026)
    6.2 North America Central Nervous System (CNS) Drug Revenue by Application (2016-2026)
    6.3 North America Central Nervous System (CNS) Drug Market Size by Country
        6.3.1 North America Central Nervous System (CNS) Drug Revenue by Country (2016-2026)
        6.3.2 United States Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
        6.3.3 Canada Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
        6.3.4 Mexico Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Central Nervous System (CNS) Drug Revenue by Type (2016-2026)
    7.2 Europe Central Nervous System (CNS) Drug Revenue by Application (2016-2026)
    7.3 Europe Central Nervous System (CNS) Drug Market Size by Country
        7.3.1 Europe Central Nervous System (CNS) Drug Revenue by Country (2016-2026)
        7.3.2 Germany Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
        7.3.3 France Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
        7.3.5 Russia Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
        7.3.6 Italy Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Central Nervous System (CNS) Drug Revenue by Type (2016-2026)
    8.2 Asia-Pacific Central Nervous System (CNS) Drug Revenue by Application (2016-2026)
    8.3 Asia-Pacific Central Nervous System (CNS) Drug Market Size by Region
        8.3.1 Asia-Pacific Central Nervous System (CNS) Drug Revenue by Region (2016-2026)
        8.3.2 China Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
        8.3.3 Japan Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
        8.3.4 South Korea Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
        8.3.5 India Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
        8.3.7 Australia Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Central Nervous System (CNS) Drug Revenue by Type (2016-2026)
    9.2 South America Central Nervous System (CNS) Drug Revenue by Application (2016-2026)
    9.3 South America Central Nervous System (CNS) Drug Market Size by Country
        9.3.1 South America Central Nervous System (CNS) Drug Revenue by Country (2016-2026)
        9.3.2 Brazil Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
        9.3.3 Argentina Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Central Nervous System (CNS) Drug Revenue by Type (2016-2026)
    10.2 Middle East & Africa Central Nervous System (CNS) Drug Revenue by Application (2016-2026)
    10.3 Middle East & Africa Central Nervous System (CNS) Drug Market Size by Country
        10.3.1 Middle East & Africa Central Nervous System (CNS) Drug Revenue by Country (2016-2026)
        10.3.2 Turkey Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)
        10.3.4 UAE Central Nervous System (CNS) Drug Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Central Nervous System (CNS) Drug Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Central Nervous System (CNS) Drug Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Central Nervous System (CNS) Drug Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Central Nervous System (CNS) Drug Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Central Nervous System (CNS) Drug Revenue Market Share by Region (2021-2026)
    Table 6. Johnson & Johnson Corporate Information, Head Office, and Major Competitors
    Table 7. Johnson & Johnson Major Business
    Table 8. Johnson & Johnson Central Nervous System (CNS) Drug Product and Solutions
    Table 9. Johnson & Johnson Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Pfizer Inc Corporate Information, Head Office, and Major Competitors
    Table 11. Pfizer Inc Major Business
    Table 12. Pfizer Inc Central Nervous System (CNS) Drug Product and Solutions
    Table 13. Pfizer Inc Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Novartis AG Corporate Information, Head Office, and Major Competitors
    Table 15. Novartis AG Major Business
    Table 16. Novartis AG Central Nervous System (CNS) Drug Product and Solutions
    Table 17. Novartis AG Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. GSK Corporate Information, Head Office, and Major Competitors
    Table 19. GSK Major Business
    Table 20. GSK Central Nervous System (CNS) Drug Product and Solutions
    Table 21. GSK Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Eli Lilly Corporate Information, Head Office, and Major Competitors
    Table 23. Eli Lilly Major Business
    Table 24. Eli Lilly Central Nervous System (CNS) Drug Product and Solutions
    Table 25. Eli Lilly Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. Teva Corporate Information, Head Office, and Major Competitors
    Table 27. Teva Major Business
    Table 28. Teva Central Nervous System (CNS) Drug Product and Solutions
    Table 29. Teva Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Otsuka Pharmaceutical Co., Ltd Corporate Information, Head Office, and Major Competitors
    Table 31. Otsuka Pharmaceutical Co., Ltd Major Business
    Table 32. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Product and Solutions
    Table 33. Otsuka Pharmaceutical Co., Ltd Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Biogen Inc Corporate Information, Head Office, and Major Competitors
    Table 35. Biogen Inc Major Business
    Table 36. Biogen Inc Central Nervous System (CNS) Drug Product and Solutions
    Table 37. Biogen Inc Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors
    Table 39. Boehringer Ingelheim Major Business
    Table 40. Boehringer Ingelheim Central Nervous System (CNS) Drug Product and Solutions
    Table 41. Boehringer Ingelheim Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Roche Corporate Information, Head Office, and Major Competitors
    Table 43. Roche Major Business
    Table 44. Roche Central Nervous System (CNS) Drug Product and Solutions
    Table 45. Roche Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. UCB Corporate Information, Head Office, and Major Competitors
    Table 47. UCB Major Business
    Table 48. UCB Central Nervous System (CNS) Drug Product and Solutions
    Table 49. UCB Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. Tekeda Corporate Information, Head Office, and Major Competitors
    Table 51. Tekeda Major Business
    Table 52. Tekeda Central Nervous System (CNS) Drug Product and Solutions
    Table 53. Tekeda Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 54. Shanghai Fosun Corporate Information, Head Office, and Major Competitors
    Table 55. Shanghai Fosun Major Business
    Table 56. Shanghai Fosun Central Nervous System (CNS) Drug Product and Solutions
    Table 57. Shanghai Fosun Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 58. Jiangsu Nhwa Pharmaceutical Co., Ltd. Corporate Information, Head Office, and Major Competitors
    Table 59. Jiangsu Nhwa Pharmaceutical Co., Ltd. Major Business
    Table 60. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Product and Solutions
    Table 61. Jiangsu Nhwa Pharmaceutical Co., Ltd. Central Nervous System (CNS) Drug Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 62. Global Central Nervous System (CNS) Drug Revenue (USD Million) by Players (2019-2021)
    Table 63. Global Central Nervous System (CNS) Drug Revenue Share by Players (2019-2021)
    Table 64. Breakdown of Central Nervous System (CNS) Drug by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 65. Central Nervous System (CNS) Drug Players Head Office, Products and Services Provided
    Table 66. Central Nervous System (CNS) Drug Mergers & Acquisitions in the Past Five Years
    Table 67. Central Nervous System (CNS) Drug New Entrants and Expansion Plans
    Table 68. Global Central Nervous System (CNS) Drug Revenue (USD Million) by Type (2016-2021)
    Table 69. Global Central Nervous System (CNS) Drug Revenue Share by Type (2016-2021)
    Table 70. Global Central Nervous System (CNS) Drug Revenue Forecast by Type (2021-2026)
    Table 71. Global Central Nervous System (CNS) Drug Revenue by Application (2016-2021)
    Table 72. Global Central Nervous System (CNS) Drug Revenue Forecast by Application (2021-2026)
    Table 73. North America Central Nervous System (CNS) Drug Revenue by Type (2016-2021) & (USD Million)
    Table 74. North America Central Nervous System (CNS) Drug Revenue by Type (2021-2026) & (USD Million)
    Table 75. North America Central Nervous System (CNS) Drug Revenue by Application (2016-2021) & (USD Million)
    Table 76. North America Central Nervous System (CNS) Drug Revenue by Application (2021-2026) & (USD Million)
    Table 77. North America Central Nervous System (CNS) Drug Revenue by Country (2016-2021) & (USD Million)
    Table 78. North America Central Nervous System (CNS) Drug Revenue by Country (2021-2026) & (USD Million)
    Table 79. Europe Central Nervous System (CNS) Drug Revenue by Type (2016-2021) & (USD Million)
    Table 80. Europe Central Nervous System (CNS) Drug Revenue by Type (2021-2026) & (USD Million)
    Table 81. Europe Central Nervous System (CNS) Drug Revenue by Application (2016-2021) & (USD Million)
    Table 82. Europe Central Nervous System (CNS) Drug Revenue by Application (2021-2026) & (USD Million)
    Table 83. Europe Central Nervous System (CNS) Drug Revenue by Country (2016-2021) & (USD Million)
    Table 84. Europe Central Nervous System (CNS) Drug Revenue by Country (2021-2026) & (USD Million)
    Table 85. Asia-Pacific Central Nervous System (CNS) Drug Revenue by Type (2016-2021) & (USD Million)
    Table 86. Asia-Pacific Central Nervous System (CNS) Drug Revenue by Type (2021-2026) & (USD Million)
    Table 87. Asia-Pacific Central Nervous System (CNS) Drug Revenue by Application (2016-2021) & (USD Million)
    Table 88. Asia-Pacific Central Nervous System (CNS) Drug Revenue by Application (2021-2026) & (USD Million)
    Table 89. Asia-Pacific Central Nervous System (CNS) Drug Revenue by Region (2016-2021) & (USD Million)
    Table 90. Asia-Pacific Central Nervous System (CNS) Drug Revenue by Region (2021-2026) & (USD Million)
    Table 91. South America Central Nervous System (CNS) Drug Revenue by Type (2016-2021) & (USD Million)
    Table 92. South America Central Nervous System (CNS) Drug Revenue by Type (2021-2026) & (USD Million)
    Table 93. South America Central Nervous System (CNS) Drug Revenue by Application (2016-2021) & (USD Million)
    Table 94. South America Central Nervous System (CNS) Drug Revenue by Application (2021-2026) & (USD Million)
    Table 95. South America Central Nervous System (CNS) Drug Revenue by Country (2016-2021) & (USD Million)
    Table 96. South America Central Nervous System (CNS) Drug Revenue by Country (2021-2026) & (USD Million)
    Table 97. Middle East & Africa Central Nervous System (CNS) Drug Revenue by Type (2016-2021) & (USD Million)
    Table 98. Middle East & Africa Central Nervous System (CNS) Drug Revenue by Type (2021-2026) & (USD Million)
    Table 99. Middle East & Africa Central Nervous System (CNS) Drug Revenue by Application (2016-2021) & (USD Million)
    Table 100. Middle East & Africa Central Nervous System (CNS) Drug Revenue by Application (2021-2026) & (USD Million)
    Table 101. Middle East & Africa Central Nervous System (CNS) Drug Revenue by Country (2016-2021) & (USD Million)
    Table 102. Middle East & Africa Central Nervous System (CNS) Drug Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Central Nervous System (CNS) Drug Picture
    Figure 2. Global Central Nervous System (CNS) Drug Revenue Market Share by Type in 2020
    Figure 3. Prescription Drugs
    Figure 4. OTC
    Figure 5. Central Nervous System (CNS) Drug Revenue Market Share by Application in 2020
    Figure 6. MS Therapeutics Picture
    Figure 7. Antipsychotic Drugs Picture
    Figure 8. Depression Drugs Picture
    Figure 9. Epilepsy Drugs Picture
    Figure 10. Others Picture
    Figure 11. Global Central Nervous System (CNS) Drug Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 12. Global Central Nervous System (CNS) Drug Revenue and Forecast (2016-2026) & (USD Million)
    Figure 13. Global Central Nervous System (CNS) Drug Revenue Market Share by Region (2016-2026)
    Figure 14. Global Central Nervous System (CNS) Drug Revenue Market Share by Region in 2020
    Figure 15. North America Central Nervous System (CNS) Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 16. Europe Central Nervous System (CNS) Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 17. Asia-Pacific Central Nervous System (CNS) Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 18. South America Central Nervous System (CNS) Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Middle East and Africa Central Nervous System (CNS) Drug Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 20. Central Nervous System (CNS) Drug Market Drivers
    Figure 21. Central Nervous System (CNS) Drug Market Restraints
    Figure 22. Central Nervous System (CNS) Drug Market Trends
    Figure 23. Johnson & Johnson Recent Developments and Future Plans
    Figure 24. Pfizer Inc Recent Developments and Future Plans
    Figure 25. Novartis AG Recent Developments and Future Plans
    Figure 26. GSK Recent Developments and Future Plans
    Figure 27. Eli Lilly Recent Developments and Future Plans
    Figure 28. Teva Recent Developments and Future Plans
    Figure 29. Otsuka Pharmaceutical Co., Ltd Recent Developments and Future Plans
    Figure 30. Biogen Inc Recent Developments and Future Plans
    Figure 31. Boehringer Ingelheim Recent Developments and Future Plans
    Figure 32. Roche Recent Developments and Future Plans
    Figure 33. UCB Recent Developments and Future Plans
    Figure 34. Tekeda Recent Developments and Future Plans
    Figure 35. Shanghai Fosun Recent Developments and Future Plans
    Figure 36. Jiangsu Nhwa Pharmaceutical Co., Ltd. Recent Developments and Future Plans
    Figure 37. Global Central Nervous System (CNS) Drug Revenue Share by Players in 2020
    Figure 38. Central Nervous System (CNS) Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 39. Global Top 3 Players Central Nervous System (CNS) Drug Revenue Market Share in 2020
    Figure 40. Global Top 10 Players Central Nervous System (CNS) Drug Revenue Market Share in 2020
    Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 42. Global Central Nervous System (CNS) Drug Revenue Share by Type in 2020
    Figure 43. Global Central Nervous System (CNS) Drug Market Share Forecast by Type (2021-2026)
    Figure 44. Global Central Nervous System (CNS) Drug Revenue Share by Application in 2020
    Figure 45. Global Central Nervous System (CNS) Drug Market Share Forecast by Application (2021-2026)
    Figure 46. North America Central Nervous System (CNS) Drug Sales Market Share by Type (2016-2026)
    Figure 47. North America Central Nervous System (CNS) Drug Sales Market Share by Application (2016-2026)
    Figure 48. North America Central Nervous System (CNS) Drug Revenue Market Share by Country (2016-2026)
    Figure 49. United States Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Canada Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Mexico Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Europe Central Nervous System (CNS) Drug Sales Market Share by Type (2016-2026)
    Figure 53. Europe Central Nervous System (CNS) Drug Sales Market Share by Application (2016-2026)
    Figure 54. Europe Central Nervous System (CNS) Drug Revenue Market Share by Country (2016-2026)
    Figure 55. Germany Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. France Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. United Kingdom Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Russia Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Italy Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Asia-Pacific Central Nervous System (CNS) Drug Sales Market Share by Type (2016-2026)
    Figure 61. Asia-Pacific Central Nervous System (CNS) Drug Sales Market Share by Application (2016-2026)
    Figure 62. Asia-Pacific Central Nervous System (CNS) Drug Revenue Market Share by Region (2016-2026)
    Figure 63. China Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Japan Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. South Korea Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. India Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Southeast Asia Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Australia Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. South America Central Nervous System (CNS) Drug Sales Market Share by Type (2016-2026)
    Figure 70. South America Central Nervous System (CNS) Drug Sales Market Share by Application (2016-2026)
    Figure 71. South America Central Nervous System (CNS) Drug Revenue Market Share by Country (2016-2026)
    Figure 72. Brazil Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Argentina Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Middle East and Africa Central Nervous System (CNS) Drug Sales Market Share by Type (2016-2026)
    Figure 75. Middle East and Africa Central Nervous System (CNS) Drug Sales Market Share by Application (2016-2026)
    Figure 76. Middle East and Africa Central Nervous System (CNS) Drug Revenue Market Share by Country (2016-2026)
    Figure 77. Turkey Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. Saudi Arabia Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. UAE Central Nervous System (CNS) Drug Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Johnson & Johnson
Pfizer Inc
Novartis AG
GSK
Eli Lilly
Teva
Otsuka Pharmaceutical Co., Ltd
Biogen Inc
Boehringer Ingelheim
Roche
UCB
Tekeda
Shanghai Fosun
Jiangsu Nhwa Pharmaceutical Co., Ltd.

Related Reports

Global Central Nervous System (CNS) Drug Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Central Nervous System (CNS) Drug Market 2022 by Company, Regions, Type and Application, Forecast to 2028

date 18 Jan 2022

date Pharma & Healthcare

The Central Nervous System (CNS) Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Product Tags

central nervous system cns drug

Central Nervous System (CNS) Drug

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>